Condition-Specific Health
Tegoprubart Islet Transplant Trial Posts Updated T1D Data
Immunosuppression mechanism under scrutiny as transplant tolerance data edges closer to clinical relevance for metaboli…
Condition-Specific Health 100 stories
Condition-Specific Health
FDA Accepts BLA for Vedolizumab Biosimilar AVT16 from Alvotech
The gut-health biologics pipeline inches forward as a vedolizumab biosimilar clears a key regulatory milestone — with i…
Condition-Specific Health
FDA Accepts BLA for AVT16, Vedolizumab Biosimilar Targeting IBD
The gut-targeted integrin inhibitor category draws biosimilar competition as regulators advance interchangeability revi…
Condition-Specific Health
FDA Accepts BLA for AVT16, Proposed Vedolizumab Biosimilar
The BLA acceptance marks a regulatory milestone for the gut-inflammation biologics pipeline, with biosimilar competitio…
Condition-Specific Health
HDV-Insulin Lispro Cuts Hypoglycemia in Phase 2b Type 1 Diabetes Trial
Hepatocyte-directed vesicle technology positions the delivery platform at the intersection of pharma and advanced nutra…
Condition-Specific Health
Survodutide Phase III Cuts Visceral Fat 34%, Liver Fat 63% in Obesity Trials
Results published simultaneously in NEJM and Nature Medicine signal a new mechanistic benchmark for metabolic-health fo…
![SlimTide Capsules [UPDATED WARNING 2026] Slim Tide Uncovering the Real Truth Behind the Trending Weight Loss Supplement](https://functional.news/public/functional/uploads/exogenous-ketone-supplements-under-scrutiny-as-bhb-claims-multiply-card.jpg)
Condition-Specific Health
Exogenous Ketone Supplements Under Scrutiny as BHB Claims Multiply
With BHB blends flooding e-commerce channels, operators and formulators face mounting pressure to substantiate ketone-d…
Condition-Specific Health
Men's Vitality Supplement Category Draws Scrutiny as Claims Multiply
As the men's wellness segment expands, operators and formulators face tightening expectations around evidence-based pos…
Condition-Specific Health
CLN-978 T Cell Engager Shows Remissions in SLE and RA Trial
Early-phase data presented at EULAR 2026 positions B-cell depletion as a credible mechanism in autoimmune disease manag…
Condition-Specific Health
Ribupatide Phase Data Surfaces at ADA 2026 via Hengrui-Kailera
As the metabolic health ingredient space watches GLP-1 mimetic botanicals gain shelf space, pharma-grade peptide data c…
Condition-Specific Health
Icovamenib Posts HbA1c, C-Peptide Gains in Type 1 Diabetes Trial
Biomea Fusion also flags muscle-preservation and fat-reduction signals, positioning the menin inhibitor as a potential …
Condition-Specific Health
Memocept Nootropic Stack Faces Customer Complaints and Efficacy Scrutiny
The episode underscores persistent industry pressure to back cognitive structure-function claims with peer-reviewed cli…